University of Oxford to study nasal administration of COVID-19 vaccine
The University of Oxford is launching a study investigating the delivery of the ChAdOx1 nCoV-19 coronavirus vaccine using a nasal spray. The Phase I trial, which will enrol 30 healthy volunteers aged 18–40, will investigate the level of immune system responses generated by the vaccine using this delivery technique, as well as monitoring safety and for any adverse reactions. All of the volunteers will receive the same vaccine that is currently being delivered by intramuscular injection as part of the national rollout of the ChAdOx1 nCoV-19 vaccine. The volunteers, who will be drawn from the local Oxford region, will be followed for a total of four months. The vaccine will be delivered using an intranasal spray device, similar to many over-the-counter hay fever nasal sprays.
For further information on the trial, including how to participate, visit: www.jenner.ac.uk/volunteer/recruiting-trials/covid-19-vaccine-intranasal-study-cov008